We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.55%
10 Year Est. Return
+237.03%
AUM
$4.01B
AUM Growth
+$587M
Cap. Flow
+$288M
Cap. Flow %
7.17%
Top 10 Hldgs %
42.99%
Holding
977
New
112
Increased
490
Reduced
208
Closed
80

Sector Composition

Rank Sector Weight
1 Technology 14.8%
2 Consumer Discretionary 9.59%
3 Financials 7.01%
4 Healthcare 3.38%
5 Industrials 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZTA icon
326
Azenta
AZTA
$1.48B
$1.04M 0.03%
10,127
+2,583
+34% +$280K
P
327
Everpure Inc
P
$29.9B
$1.04M 0.03%
32,016
-142
-0.4% -$4.12K
NVS icon
328
Novartis
NVS
$297B
$1.04M 0.03%
11,917
-206
-2% -$17.1K
CARR icon
329
Carrier Global
CARR
$52.8B
$1.04M 0.03%
19,112
+11,400
+148% +$615K
SYNH
330
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.03M 0.03%
9,995
+109
+1% +$10.5K
VNO icon
331
Vornado Realty Trust
VNO
$7.38B
$1.02M 0.03%
24,470
+6,120
+33% +$264K
ZTS icon
332
Zoetis
ZTS
$30.5B
$1.01M 0.03%
4,167
+1,006
+32% +$220K
IWP icon
333
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$1.01M 0.03%
8,752
-244
-3% -$28.5K
NEE icon
334
NextEra Energy
NEE
$177B
$1.01M 0.03%
10,807
+3,614
+50% +$312K
EW icon
335
Edwards Lifesciences
EW
$51.7B
$1M 0.03%
7,760
+2,490
+47% +$290K
HSBC icon
336
HSBC
HSBC
$356B
$1M 0.03%
33,312
+933
+3% +$27.2K
POOL icon
337
Pool Corp
POOL
$7.5B
$1M 0.03%
1,769
+29
+2% +$15.2K
PRFT
338
DELISTED
Perficient Inc
PRFT
$1M 0.03%
7,759
-3,236
-29% -$426K
MTX icon
339
Minerals Technologies
MTX
$2.34B
$997K 0.02%
13,630
+51
+0.4% +$3.67K
C icon
340
Citigroup
C
$226B
$995K 0.02%
16,487
+7,127
+76% +$474K
DAVA icon
341
Endava
DAVA
$156M
$991K 0.02%
5,899
+68
+1% +$10.5K
JLL icon
342
Jones Lang LaSalle
JLL
$16.7B
$989K 0.02%
3,669
-1,217
-25% -$314K
EXPE icon
343
Expedia Group
EXPE
$37.3B
$988K 0.02%
5,465
-28
-0.5% -$4.76K
SFM icon
344
Sprouts Farmers Market
SFM
$8.01B
$985K 0.02%
33,184
+10,000
+43% +$250K
VRTX icon
345
Vertex Pharmaceuticals
VRTX
$126B
$985K 0.02%
4,483
+1,861
+71% +$362K
STTK icon
346
Shattuck Labs
STTK
$694M
$982K 0.02%
115,339
TAP icon
347
Molson Coors Class B
TAP
$8.1B
$976K 0.02%
+21,060
New +$966K
SUB icon
348
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$973K 0.02%
9,057
CPRT icon
349
Copart
CPRT
$27.5B
$970K 0.02%
25,612
+760
+3% +$28.2K
URA icon
350
Global X Uranium ETF
URA
$6.22B
$969K 0.02%
+42,463
New +$1.12M

Similar funds

Pathstone Family Office's Q4 2021 Portfolio in Review

As of Q4 2021, Pathstone Family Office held 977 positions worth $4.01B, up 17% from $3.42B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pathstone Family Office deployed $288M of net new capital in Q4 2021, opening 112 new positions and adding to 490 existing holdings. Its largest new stake was State Street SPDR Portfolio Developed World ex-US ETF: 3,153,326 shares worth $116M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares MSCI ACWI ETF, an estimated $27.2M trimmed.

  • Pathstone Family Office's largest Q4 2021 buy was State Street SPDR Portfolio Developed World ex-US ETF: 3,153,326 shares worth $116M.
  • Pathstone Family Office added most to iShares Core MSCI Emerging Markets ETF in Q4 2021, an estimated $23.6M increase.
  • Pathstone Family Office's biggest Q4 2021 reduction was iShares MSCI ACWI ETF, cutting an estimated $27.2M.
  • Pathstone Family Office fully exited Loral Space and Communications, Inc. in Q4 2021, selling an estimated $7.56M.
  • Pathstone Family Office's ten largest holdings make up 43% of its $4.01B portfolio in Q4 2021.
  • Pathstone Family Office opened 112 new positions and closed 80 in Q4 2021.
  • Pathstone Family Office's portfolio value rose 17% quarter-over-quarter to $4.01B.

Based on Pathstone Family Office's 13F filing for Q4 2021, filed 14 Feb 2022.